Resultados de la búsqueda 471-480 of 19040 for Two-phase
Phase 2 Trial Of Voyager V1 In Combination With Cemiplimab In Cancer Patients ... In the phase II part, to evaluate the preliminary antitumor activity of two ...
The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...
Note: Mayo Clinic is only participating in the Phase 2 - Cohort 3 (UPLIFT) portion of the study. Mayo Clinic will not be participating in the QTC sub-study ...
... two future steps: A Long Term Study of Molecular and Structural Imaging in Atypical Alzheimer's Disease. Rochester, Minn. The purpose of this study is to ...
This study aims to determine cancer control at 2 years after study registration. ... Participant eligibility includes age, gender, type and stage of disease, and ...
The purpose of this study is to evaluate the safety and tolerability and determine the recommended Phase 2 dose (RP2D) of YH001 when given with envafolimab ...
The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...
The purpose of phase 1 of this trial is to ... There is evidence that neurodegenerative changes precede clinical symptoms in Alzheimer's disease by two decades ( ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?